VALANX Biotech
PrivateLast Round
Series A
Mar 12, 2026
Total Funding Raised
$3.55M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
VALANX Biotech is a biotechnology company that has developed a proprietary platform for site-specific protein conjugation to create antibody-drug conjugates (ADCs) and other biologics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VALANX Biotech Comparables
Compare VALANX Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BrickBio, Inc. | 87% | |
| Catena Biosciences | 84% | |
| Onegene Biotechnology | 79% | |
VALANX Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 12, 2026 | ||||
| VC Round | Nov 7, 2023 | ||||
| Seed | May 1, 2020 | ||||
| Accelerator | Jun 16, 2017 |
VALANX Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| tecnet equity | Seed, Series A, VC Round |
| Skygene | Series A, VC Round |
| xista science ventures | Seed, VC Round |
| xista science ventures | Series A |
| RebelBio | Accelerator |
| SOSV | Seed, Series A, VC Round, Accelerator |
| Fondation Fournier-Majoie | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2026
Grew 21% QoQ, from 14 to 17 employees.
- Apr 15, 2026
Monthly visitors increased 144% MoM, reaching 268.
VALANX Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VALANX Biotech's valuation, stock price, and market status.